Founding offer · lifetime membership for a single £24, exclusive to our first members · closes 20 June Claim your place →
Global Research Partnerships £24 Lifetime Log inCreate free account

Funded Projects › HORIZON

GlycoNoVi · Understanding the Role of Glycans in Human Norovirus Infection: a Key to Unlock New Therapies

HORIZONStatus: SIGNED1 January 202331 December 2026EU funding €2,412,295Call HORIZON-MSCA-2021-DN-01

Glycans are carbohydrate structures ubiquitously found on the surface of cells and take part in many biological processes, including cell signaling and neoplasia. Research on glycans is challenging in part due to the limited availability of biologically relevant synthetic glycans and to technical challenges in the analysis of glycan-protein interactions. Glycans also exhibit key roles in viral infections, mediating virus attachment and entry. Human noroviruses (NoVs) are the major cause of viral gastroenteritis and foodborne illnesses causing morbidity, mortality and economic losses. NoV infections are self-limiting in healthy individuals but are associated with severe complications in immunocompromised individuals, the elderly and young children. In addition, frequently occurring new NoV genotypes and variants can cause large outbreaks and epidemics worldwide. Very little is known about NoV infections in most non-human hosts and the close genetic similarities between some animal and human NoVs leads to the realistic hypothesis that the virus might jump the species barrier triggering pandemic variants. Importantly, no therapy is currently available to treat or prevent NoV infections. The requirement for NoVs to attach to specific glycans to infect hosts’ tissues, and cells, has been well established but the underlying mechanisms remain to be elucidated. Going beyond the state-of-the-art, the overall aims of GlycoNoVi is training 9 researchers to address knowledge gaps on NoV glycan interactions and investigate the exciting possibility of developing synthetic glycans as antiviral strategies to treat NoV infection. These aims will be achieved bringing together 5 academic and 3 industrial leaders in glycoscience, glycovirology and NoV field and relying on a multidisciplinary and interconnected approach which is declinate in research-oriented WP1-5 and WP6-8 focused respectively on training, outreach and coordination.

Consortium · 15 organisations

coordinator

UNIVERSITA DEGLI STUDI DI FIRENZE

IT · €518,875

associatedPartner

THE UNIVERSITY OF MANCHESTER

UK

associatedPartner

UNIVERSITEIT GENT

BE

participant

INBIOSE

BE · €262,620

participant

REACT4LIFE SPA

IT · €259,438

participant

AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS

ES · €251,971

associatedPartner

UNIVERSITE GRENOBLE ALPES

FR

associatedPartner

DANMARKS TEKNISKE UNIVERSITET

DK

participant

GLYCOM AS

DK · €301,788

associatedPartner

UNIVERSITA' DEGLI STUDI DI MILANO-BICOCCA

IT

participant

ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM

NL · €274,370

participant

CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRS

FR · €282,694

participant

UNIVERSITAET zu LUEBECK

DE · €260,539

associatedPartner

ICENI GLYCOSCIENCE LIMITED

UK

associatedPartner

UNIVERSIDAD DE SEVILLA

ES

Research fields

View the official record on CORDIS →

← Find collaborators and more funded projects

Source: CORDIS, Publications Office of the European Union. Global Research Partnerships surfaces open EU research data to help you find collaborators; we are not affiliated with the European Union.